Step 1Open Submission
Teams consisting of at least two eligible partnering organizations submit an innovative concept to translate patient insights into improvements in the drug development process.
Step 2Finalist Selection
Challenge judges select four teams whose concepts illustrate innovative solutions in the drug development process that could only be possible through their teams’ collaboration.
Step 3Virtual Accelerator
Four finalist teams each receive access to mentors to help hone their concepts and build their implementation plans.
Step 4Finalist Event
Four finalist teams present their collaboration model, refined concept, and implementation plan to the judges at the finalist event in the New York metropolitan area.
Step 5Winner Announced
One winning team is awarded $100,000. In addition, the team will be offered the opportunity to access additional expertise and resources (nonmonetary) through Sanofi US.
The overarching goal of each solution should be to improve the treatment or medical experience for the patient on their journey to improving health. Solutions should also advance research.
The proposal should focus on one or more of the following patient-centric opportunities to:
- Provide a direct path for patients to influence discovery or preclinical stages of research (may include specific information sharing of biomarkers, data in biobanks, better understanding of the disease).
- Support the process where research insight developed in the lab may be put into practice at a patient or population level (i.e. from “bench-to-bedside”).
- Influence collaborative protocol development across patient advocacy organizations, the public, and industry to drive mutual benefit.
- Influence policies and processes, as well as timing and methods of interaction with patients during the R&D process, including clinical trials. The proposal should describe the methodology and the means by which patient input will impact specific stages of research.
- Increase value for participants while also increasing efficiencies in the process (e.g., reducing clinical trial recruitment times).
The proposal should include measurable goals with a clear view towards creating a proof-of-concept.
Teams must be made up of two or more partnering organizations. The primary entrant must be a non-profit patient, provider or professional association (501(c)3, 501(c)4 or 501(c)6), partnering with one or more of the following: another non-profit patient, provider or professional association (501(c)3, 501(c)4, or 501(c)6), and/or an academic institution. A multidisciplinary approach is highly encouraged. All team members must be legally based in the U.S.
Sanofi US believes that better approaches to translating patient insights into improvements in the drug development process can be created by encouraging collaboration among patient advocates. For the Collaborate | Innovate challenge, collaborations among at least two eligible partners that yield exceptional solutions will be recognized by an independently selected panel of judges and rewarded in the following ways:
- 4 Finalists
- From all of the submissions, four finalist teams will be selected by the judges.
- The four finalist teams will have the opportunity to participate in the Virtual Accelerator, refine their concepts and develop implementation plans in preparation for the Finalist Event.
- 1 Winner
- Following the Finalist Event, one winning team will be selected by the judges.
- The winning team will receive $100,000.
- The winner will have the opportunity to access additional expertise and resources (nonmonetary) through Sanofi US.
Official Rules and Terms & Conditions
PIPH Innovation Challenge: Collaborate | Innovate
No Purchase Necessary
Sponsored by Sanofi US, 55 Corporate Dr., Bridgewater, NJ 08807 (“Sponsor”). Void where prohibited. All entrants agree to be bound by these Official Rules.
The PIPH Innovation Challenge: Collaborate | Innovate (“Competition” or “Contest”) is open to non-profit (501c3, 501c4, 501c6) patient, provider or professional associations, and academic institutions. Submissions from 2 or more organizations working in collaboration are accepted. The primary entrant must be a non-profit (501c3, 501c4, 501c6) patient, provider, or professional association. Employees, officers and directors of Sponsor and any of its affiliates, agents, parent or subsidiary companies and advertising and promotion agencies, and members of their immediate families (spouses, parents, children, and siblings and their spouses) and/or those living in the same household of each (whether or not related) are not eligible to participate. By participating, you agree to these Official Rules and the decisions of Sponsor, which are final and binding in all respects. Void outside of the 50 United States and the District of Columbia, and where prohibited, taxed or restricted by law. All federal, state and local laws and regulations apply.
Submissions for the Competition can be made beginning 8:00am EST December 9, 2013, until February 23, 2014, at 11:59pm EST. Sponsor will announce four finalists on www.collaborateinnovate.com (the “Website”) on March 17, 2014, and each finalist will receive an e-mail notification. The four finalists will be provided with one-on-one virtual mentorship from March 18 to May 8, 2014. Finalists will take part in a “Finalist Event” on May 9, 2014 in the New York Metropolitan area. Videos of the Finalist Event presentations will be streamed to the Website. Sponsor will announce one winner on the Website on May 9, 2014.
Submissions are made via entry form on the Website from December 9, 2013 through February 23, 2014.
A submission should: (1) Improve the treatment or medical experience for the patient on their journey to improving health and advance research; and (2) Include measurable goals with a clear view towards creating a proof-of-concept.
Additionally, a submission is a concept that also satisfies AT LEAST ONE of the following criteria: (1) Provides a direct path for patients to influence discovery or preclinical stages of research; (2) Supports the process where research insight developed in the lab may be put into practice at a patient or population level; (3) Influences collaborative protocol development across patient advocacy organizations, the public, and industry to drive mutual benefit; (4) Influences policies and processes, as well as timing and methods of interaction with patients during the R&D process, including clinical trials; (5) Increases value for participants while also increasing efficiencies in the process.
A concept is an outline of a proposed product, service, or initiative that has emerged through the teams’ collaboration and sharing of resources and insights.
A submitted concept should describe the methodology and means for patient input to be translated into specific stages of research, and must articulate the benefit to a patient within a clearly defined target audience, outline expected impact, and timeline for concept execution.
A submission does not have to be developed beyond the concept or planning phase.
Teams can make multiple submissions, but each entry form must contain only one complete solution
The proposed solution needs to have been created in its ENTIRETY by the submitting team, i.e. it must not infringe or violate the rights of any third parties, including, but not limited to the copyrights, patents, trademarks, trade secrets, and right of publicity/privacy. It is the responsibility of the submitting party to verify all rights.
Entries must be made in the English language.
TERMS & CONDITIONS
TO PARTICIPATE IN THE PROMOTION:
(A) To Enter: Access the Website and complete the information fields; specifically, team primary and secondary name and email addresses, partnering organization names and websites, 3 team collaboration questions, 8 concept detail questions, and visual media.
All entry information and submissions, including team and concept details, shall be collectively referred to herein as the “Submissions” or each as a “Submission.” Prior to uploading your Submission, you must also affirmatively confirm that you have read, understand and agree to these Official Rules by clicking on the check box on the Submission form.
(B) Submission: Each Submission must consist of one (1) textual submission and one (1) visual asset. Submit your own original Submission to the submission page on the Website. Text Submissions must be accompanied by some type of visual media describing the proposed concept: a diagram, screenshot, doodle, a wireframe, or similar schematic.
(C) Submission Parameters: Submissions (i) must be the 100% original and sole creation of the entrant, and all right, title and interest, including but not limited to the copyright in any Submission, must be owned solely by the submitting entrant, (ii) may not have been published anywhere prior to the date of entry into this Promotion, (iii) may not infringe upon any third party’s rights, including but not limited to copyright, patent or trademarks/tradenames/logos, or rights of privacy or publicity, or contain material that is or may be considered defamatory, slanderous or libelous, or portray or depict any person, product or entity in a false light, (iv) must be truthful and accurate in all respects, (v) may not violate any law, rule or regulation, (vi) may not contain any virus, bugs or other deleterious material, and (vii) may not contain or depict, for example but not limited to, profanity, defamatory statements, words or symbols widely considered offensive to individuals of any certain race, ethnicity, religious, sexual orientation or socioeconomic group, threats to any person, place, business, group or world peace; and each entrant warrants and represents that his/her Submission complies with all of those conditions. Submissions cannot contain, among other things, the trademark, tradename or logo of any third party or entity or product (including but not limited to the trademark, tradename or logo of any product competitive with any product of Sponsor, and including, but not limited to, on clothing), cannot contain, name, depict or describe any person (living, dead or fictional) other than the entrant and cannot contain any material that is protected by copyright. Any non-complying Submission with these Official Rules will be subject to disqualification.
By entering, each Entrant grants permission for the use of his/her Submission, and his/her name, and likeness, to be posted on the Internet (including the Website) in connection with this Challenge, and the advertising, promotion, and publicity of the Challenge, and otherwise, as stated in these Official Rules (as solely determined by Sponsor); and each Entrant warrants and represents that he/she has all right and authority to grant such permission. Notwithstanding anything to the contrary, however, there is no obligation of the Sponsor or any other person or entity to post or make any use of the Submission of any particular Entrant, or of any Entrant’s information.
(D) Submissions from Prior Winners: Prior winners of the Partners in Patient Health “Collaborate” challenge series are not eligible to participate in the Competition as the primary entrant, but may participate as secondary or tertiary members in a team.
(E) Conditions of Submission: Only fully completed entry forms are eligible. Proof of submission will not be deemed to be proof of receipt by Sponsor. Notwithstanding anything to the contrary, Sponsor reserves the right to disqualify any Submission that Sponsor, in its sole opinion, deems inappropriate. Questions concerning the Challenge will not be acknowledged or responded to, but technical questions only, for example, that may involve the inability to access the Website, or the inability to attach a visual asset to the Submission, can be sent to firstname.lastname@example.org. Submissions that do not conform to these Official Rules or are submitted in any manner other than stated in these Official Rules will be disqualified.
CONTEST WINNER DETERMINATION
(A) Judging Phase: As Submissions are received, all eligible Submissions will be judged by a panel of judges determined by Sponsor to have the required knowledge and experience to apply the judging criteria. Judging will be scored based on the official criteria of the Competition (as noted in Entry Requirements and on the Website) and based on the judgment of the panel of judges. Subject to verification and compliance with these Official Rules, the four (4) entrant teams will be selected as finalists on March 17, 2014. When notification of the finalist teams is completed, or as soon as is practical thereafter, the Submissions selected by the finalist teams will be listed on the Website for public viewing. THE JUDGING SCORES WILL NOT BE POSTED OR OTHERWISE AVAILABLE. Each of the four finalist teams will receive one-on-one mentorship to further develop their concept into a plan. Mentorship will also be provided to help strengthen their cross-organization collaboration. On May 9, 2014, the four finalist teams will present their plans to the judges in a Finalist Event in the New York Metropolitan area. The judges will evaluate each of the presentations and plans. One (1) winning team will be announced on May 9, 2014.
Representatives of the selected finalist teams must be able to attend and present at Finalist Event on May 9, 2014. If representatives from the finalist team are unable to attend, they will not be considered for the next round, and they forfeit their award monies. The Sponsor will provide a stipend to the finalist teams to defray reasonable transportation and travel costs to the Finalist Event.
NO PURCHASE NECESSARY. NO WRITTEN RESPONSE NECESSARY. A PURCHASE OR PARTICULAR RESPONSE DOES NOT IMPROVE YOUR CHANCE OF WINNING. VOID WHERE PROHIBITED. ODDS OF WINNING DEPEND ON NUMBER OF ELIGIBLE ENTRIES RECEIVED AND DETERMINATION OF JUDGES.
Sanofi US reserves the right to suspend, postpone, cease, terminate or otherwise modify the Innovation Challenge at any time, without assigning any reason, at its sole option and discretion and Sanofi US shall have no liability, whatsoever, in any such event.
Any individual or team that submits an entry to the Innovation Challenge (“Entrant”) selected as a finalist must comply with all terms and conditions set forth in these Official Rules, and winning is contingent upon fulfilling all requirements. Finalists will be selected by a panel of judges. The Challenge will occur under the guidance of Sanofi US. Entrants agree to be bound by these rules and the decision of the judges, whose decisions are final.
Potential finalist teams will be notified by e-mail by March 17, 2014. Potential winner team will be notified by e-mail by May 9, 2014. If a potential finalist, runner-up, or winner team cannot be contacted and does not reply with appropriate affidavit and contact information within three (3) days after the first attempt to contact such potential finalist, runner-up, or winner, an alternate entrant team will be selected in their place based on score and judges’ discretion. Should a finalist team drop-out or be determined ineligible, the judges may select an alternate based on scoring and at their discretion, to encourage diversity of projects.
The following prize will be awarded to 4 finalist teams: (1) mentorship to hone their collaboration and concept strategy. From these 4 finalist teams, 1 winning team (“Winner”) will be selected and receive: (1) $100,000, (2) support (nonmonetary) by Sanofi US to further evolve and develop their plan. Odds of winning dependent upon number of entries submitted and strength of entry based on the judgment of the judges.
Total estimated retail value of all prizes exceeds $100,000. There will be no substitutions for prizes. Prizes awarded are non-transferable and may not be exchanged or redeemed for cash, sold, or traded. Sponsor reserves the right to substitute a prize, in which case a prize of equal or greater value will be awarded.
The Challenge Winner will be required to participate in a follow-up with Sanofi US R&D to report on concept progress and receive counsel as needed.
Materials submitted may be published in the public domain, royalty-free, by the Challenge organizers, in conjunction with promotions of this competition. All efforts on the part of Sanofi US will be in good faith to maintain correct acknowledgment of the submitter. Sanofi US will not make the content of the submissions available to any outside party except the Panel of Judges of the contest. Please NOTE: entrants retain full intellectual property (“IP”) rights to their submitted concepts.
- All participants retain ownership of any software or research they develop or any other IP rights they create; this IP will not be used by Sanofi US unless there is explicit agreement with the participants regarding this use.
- Likewise, finalists are free to publish papers in journals of their choice or create presentations describing their submissions (including relevant excerpts from the Sanofi US material where appropriate and with the proper acknowledgment of the source).
- Sanofi US will not make the content of the submissions available to any outside party except the Judges of the contest.
- Sanofi US warrants that use of the Sanofi US material in accordance with the terms and conditions therein will not infringe the intellectual property rights of any third party. Sanofi US shall indemnify, defend and hold harmless the participant from and against any loss, damage, costs, liability and expenses (including reasonable attorneys’ fees) arising from or out of any third-party action or claim that use of the Sanofi US material in accordance with the terms and conditions therein infringes the intellectual property rights of such third party.
- Sanofi US retains all right, title, and interest in and to any materials that Sanofi US provides to participant in connection with the contest. Participants may only use such materials for the purposes of this contest and for the duration of this contest. If participants use non-Sanofi US materials, they are responsible for securing the necessary rights to use such non-Sanofi US materials for the purposes of the project. Participants warrant that the submission is original, that it has been written by the stated authors and has not been submitted elsewhere, that the submission contains no libelous or other unlawful statements and that it and does not contain any materials that violate any personal or proprietary rights of any other person or entity.
- Agreeing to receive email news updates does not affect chances of winning.
- Posting a link for the Contest on Facebook or Twitter does not increase your chances of winning. Neither Facebook nor Twitter is the Sponsor of the Contest.
In the event of a dispute, entries made by Internet will be deemed made by the authorized account holder of the e-mail address submitted at the time of entry. The "authorized account holder" is deemed the natural person who is assigned to an e-mail address by an Internet access provider, service provider or other online organization that is responsible for assigning e-mail addresses for the domain associated with the submitted e-mail address. A potential winner may be requested to provide Sanofi US with proof that the potential winner is the authorized account holder of the e-mail address associated with the winning entry. If for any reason the Challenge is not capable of running as planned, including due to infection by computer virus, bugs, tampering, unauthorized intervention, fraud, technical failure, human error or any other causes beyond the control of Sanofi US that corrupt or affect the administration, security, fairness, integrity, or proper conduct of the Challenge, Sanofi US reserves the right in their sole discretion, to disqualify any individual who tampers with the entry process, and to cancel, terminate, modify or suspend the Challenge. Sanofi US assumes no responsibility for any error, omission, interruption, deletion, defect, delay in operation or transmission, communications line failure, theft or destruction or unauthorized access to, or alteration of, entries. Sanofi US is not responsible for any problems or technical malfunction of any, computer online systems, servers, or providers, computer equipment, software, failure of any e-mail or entry to be received by Sanofi US on account of technical problems or traffic congestion on the Internet or at any web site, any combination thereof, or otherwise, including any injury or damage to entrant's or any other person's computer related to or resulting from participation or downloading any materials in the Challenge. Sanofi US is not responsible for late, lost, illegible, incomplete, stolen, or misdirected entries. CAUTION: ANY ATTEMPT BY AN ENTRANT TO DELIBERATELY DAMAGE ANY WEB SITE OR UNDERMINE THE LEGITIMATE OPERATION OF THE Challenge MAY BE A VIOLATION OF CRIMINAL AND CIVIL LAWS AND SHOULD SUCH AN ATTEMPT BE MADE, SANOFI US RESERVES THE RIGHT TO SEEK DAMAGES FROM ANY SUCH PERSON TO THE FULLEST EXTENT PERMITTED BY LAW.
DISPUTE RESOLUTION/CHOICE OF LAW: Except where prohibited, each entrant agrees that: (1) any and all disputes, claims and causes of action arising out of or connected with this Promotion shall be resolved individually, without resort to any form of class action, and exclusively by the United States District Court or the appropriate State Court located in New York; (2) any and all claims, judgments and awards shall be limited to actual out-of-pocket costs incurred, including costs associated with participating in this Promotion, but in no event attorneys’ fees; and (3) under no circumstances will participant be permitted to obtain awards for, and participant hereby waives all rights to claim, indirect, punitive, incidental and consequential damages and any other damages, other than for actual out-of-pocket expenses, and any and all rights to have damages multiplied or otherwise increased.
All issues and questions concerning the construction, validity, interpretation and enforceability of these Official Rules, or the rights and obligations of the participant and Releases in connection with the Promotion, shall be governed by, and construed in accordance with, the laws of the State of New York without giving effect to any choice of law or conflict of law rules (whether of the State of New Jersey or any other jurisdiction), which would cause the application of the laws of any jurisdiction other than the State of New York.
SPONSOR: Sanofi US US, 55 Corporate Drive, Bridgewater, NJ 08807
December 9, 2013 – Competition announced and open submissions accepted via the Collaborate | Innovate website.
February 23, 2014 – Last day to submit an entry.
March 17, 2014 – Four finalist teams announced via the Collaborate | Innovate website.
March 18 – May 8, 2014 – Four finalist teams receive mentorship to transform their concepts and develop implementation plans.
May 9, 2014 – Four finalist teams present their refined concepts and implementation plans to the judges during the Finalist Event in the New York metropolitan area. Videos of the Finalist Event will be streamed on the website. From the four finalist teams, one winning team is announced and awarded $100,000. The winning team will be offered the opportunity to access Sanofi US resources to further develop their plans.
All intellectual property and equity will remain the property of its creators throughout the entire competition. Please review the Rules and Terms & Conditions..
Please confirm your email address.